Total revenue grew 27% to $138 million, with 30% growth in surgical revenue
Adjusted EBITDA margin expanded 450 basis points
Full-year revenue and adjusted EBITDA guidance increased to $601 million ...
Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments